The present work does not exclude that the observed polymorphisms may play a role in other disease contexts or that other not yet identified polymorphisms in LAMTOR2 and LAMTOR3 may in fact contribute to breast cancer aetiology. Here, LAMTOR3 is linked to breast carcinoma.